1. Home
  2. TONX vs MDWD Comparison

TONX vs MDWD Comparison

Compare TONX & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TON Strategy Company

TONX

TON Strategy Company

HOLD

Current Price

$2.98

Market Cap

147.6M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$12.04

Market Cap

162.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TONX
MDWD
Founded
N/A
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.6M
162.2M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
TONX
MDWD
Price
$2.98
$12.04
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $30.67
AVG Volume (30 Days)
★ 182.4K
79.3K
Earning Date
11-11-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 69.21
N/A
EPS
N/A
★ N/A
Revenue
★ $32,000.00
N/A
Revenue This Year
N/A
$39.60
Revenue Next Year
N/A
$34.34
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 433.33
N/A
52 Week Low
$1.75
$11.84
52 Week High
$4.44
$19.70

Technical Indicators

Market Signals
Indicator
TONX
MDWD
Relative Strength Index (RSI) 44.30 39.47
Support Level $2.85 $11.84
Resistance Level $3.58 $14.06
Average True Range (ATR) 0.17 0.50
MACD -0.03 -0.04
Stochastic Oscillator 39.07 11.54

Price Performance

Historical Comparison
TONX
MDWD

About TONX TON Strategy Company

TON Strategy Co is a digital asset treasury and Web3 ecosystem company focused on supporting The Open Network, a public blockchain integrated with Telegram and designed for fast, scalable transactions and decentralized applications. Its core business is managing its holdings of Toncoin (TON), including staking tokens to support network validation and earn rewards, while adhering to regulatory, accounting, and risk management standards. The company also pursues Web3 initiatives to support the ecosystem's growth and adoption. It operates through MARKET. live, Go Fund Yourself, and TON segments, with MARKET.live generating maximum revenue as a multi-vendor livestream shopping platform that combines e-commerce and entertainment across social and video channels.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: